Actively Recruiting
Barts Revascularisation Registry To Understand the Characteristics, Time-trends and Outcomes in Patients With Coronary Artery Disease at Barts Heart Centre
Led by Queen Mary University of London · Updated on 2025-07-24
20000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying coronary artery disease (CAD), a leading cause of death worldwide, by collecting real-world data from patients undergoing revascularisation at Barts Heart Centre. This observational research aims to understand patient characteristics, treatment trends, and outcomes to improve risk assessment and diagnostic evaluation. The study builds on a long history of data collection in the UK and focuses on patients with CAD receiving interventional or surgical treatments. The study involves patients who have undergone percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) at the centre. Data is collected through a secure clinical database containing demographic, clinical, and outcome information. Patients are observed without additional treatment interventions as part of the study. This registry includes a wide range of patients with simple to complex coronary artery disease. Participants' data will be used to monitor outcomes such as mortality, re-admission rates, and major adverse cardiovascular events (MACE) within one year after revascularisation. The study does not require informed consent as data collection is part of routine care. The research will provide valuable real-world evidence on the safety, feasibility, and effectiveness of current revascularisation practices in a leading cardiac centre.
CONDITIONS
Brief Title
Barts Revascularisation Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 16 years or older
- Male and female patients
- Patients who have had an angiogram at Barts Heart Centre
- Patients who have undergone revascularisation
- Vulnerable adults or those unable to give consent if referred to the Interventional Cardiology team
- Informed consent is not required as patients are automatically included in the research database
You will not qualify if you...
- Patients younger than 16 years old are not included in this study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 year
Participants who undergo routine care for coronary artery disease including revascularisation are observed through data collection in a clinical database.
Data collected during routine clinical visits
Trial Site Locations
Total: 1 location
1
Barts Health NHS Trust
London, United Kingdom
Actively Recruiting
Research Team
D
Dr. Krishnaraj Rathod
D
Dr. Daniel Jones
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here